To Physicians and Investors, Biotech investing is not for the faint of heart. The sector’s volatility, driven by market sentiment, regulatory shifts, or macroeconomic events like the tariff concerns earlier this year, can test even the most seasoned investors. In early April, as fears of tariffs roiled the markets, benchmarks like the Dow, S&P 500,...